Neuropathic Pain Research
Syqe Medical Ltd. is involved in clinical research focused on diabetic peripheral neuropathic pain, with an emphasis on treatment options for persistent pain associated with diabetes mellitus. The sponsor’s trial activity reflects interest in pain relief strategies for patients with nerve-related complications.
- Diabetic peripheral neuropathic pain
- Chronic pain management
- Diabetes-related nerve pain
Its research portfolio in this area centers on therapies aimed at reducing pain intensity and improving symptom control in a difficult-to-treat neuropathic pain condition.
Medical Cannabis Applications
The sponsor studies medical cannabis as a therapeutic option for pain conditions, with particular attention to inhaled formulations containing tetrahydrocannabinol for analgesic use. This places the company within the field of cannabinoid-based treatment development.
- Medical cannabis aerosol
- THC-based therapy
- Cannabinoid analgesia
Research activity in this domain is directed toward the clinical use of cannabinoid therapeutics for pain-related indications.
Analgesic Innovation
Clinical work supported by Syqe Medical Ltd. is centered on novel approaches to analgesia, particularly delivery systems designed for patients with ongoing pain symptoms. The sponsor’s interest lies in advancing treatment options beyond conventional pain management.
- Pain intensity reduction
- Symptom control
- Inhaled pain therapies
This area of research connects drug delivery with clinical pain treatment, especially in settings where standard therapies may be insufficient.
